基于营卫理论对冠心病心绞痛患者颈部粥样硬化斑块干预的临床研究  

Clinical Study on Intervention of Atherosclerotic Plaque in the Neck of Angina Pectoris Patients with Coronary Heart Disease Based on Yingwei Theory

作　　者：张茂云 牟宗毅[2] ZHANG Maoyun;MU Zongyi(Department of Jinguikou,School of Basic Medicine,Changchun University of Chinese Medicine,Jilin Province,Changchun 130117,China;Department of Cardiology,Affiliated Hospital of Changchun University of Chinese Medicine,Jilin Province,Changchun 130021,China)

机构地区：[1]长春中医药大学基础医学院金匮教研室,吉林长春130117 [2]长春中医药大学附属医院心内科,吉林长春130021

出　　处：《中国中医药现代远程教育》2021年第2期115-117,共3页Chinese Medicine Modern Distance Education of China

基　　金：吉林省中医药管理局中医药科技项目【No.2018031】。

摘　　要：目的观察基于"营卫理论"的桂枝汤加减,治疗痰瘀互结型冠心病心绞痛的临床疗效。方法采用随机对照的研究方法,将110例冠心病患者按1∶1比例随机分成对照组和治疗组。对照组给予阿托伐他汀治疗;治疗组给予桂枝汤加减治疗。疗程为6个月。观察并记录IMT、SAQ情况。结果和阿托伐他汀相比,冠心病心绞痛痰瘀互结型的患者,服用桂枝汤加减在减少IMT方面无显著性差异(P>0.05),同时能提高SAQ的5个维度评分(P<0.01)。结论基于"营卫理论"的桂枝汤加减,在减少IMT方面与阿托伐他汀疗效相当,并能改善SAQ的5个维度评分,缓解心绞痛症状,提高生活质量,且具有良好的安全性。to observe the clinical efficacy of guizhi decoction based on yingwei theory in the treatment of the phlegm and blood stasis type of coronary heart disease angina pectoris.Treatment group given guizhi tonga subtraction treatment for 6 months to observe and record the IMT SAQ result:compared with atorvastatin,coronary heart disease angina pectoris patients with phlegm and blood stasis mutual junction,taking guizhi tonga subtraction in reduce IMT there was no significant difference(P>0.05),at the same time can improve the five dimensions of SAQ scores(P<0.01)conclusion:guizhi tonga subtraction based on the theory of the business health,reduce IMT in treatment with atorvastatin,and can improve the SAQ 5.

关 键 词：营卫理论 桂枝汤 阿托伐他汀 冠心病心绞痛 心悸 痰瘀互结型 

分 类 号：R259[医药卫生—中西医结合]